155 related articles for article (PubMed ID: 10694553)
21. Evaluation of outcome and prognostic factors in thoracic primitive neuroectodermal tumor: a study of 84 cases.
Biswas B; Agarwala S; Shukla NK; Deo S; Sharma D; Thulkar S; Vishnubhatla S; Bakhshi S
Ann Thorac Surg; 2013 Dec; 96(6):2006-14. PubMed ID: 24035307
[TBL] [Abstract][Full Text] [Related]
22. Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis.
de Bont JM; den Boer ML; Kros JM; Passier MM; Reddingius RE; Smitt PA; Luider TM; Pieters R
J Neuropathol Exp Neurol; 2007 Jun; 66(6):505-16. PubMed ID: 17549010
[TBL] [Abstract][Full Text] [Related]
23. Cytogenetic and histopathologic studies of congenital supratentorial primitive neuroectodermal tumors: a case report.
Girschick HJ; Klein R; Scheurlen WG; Kühl J
Pathol Oncol Res; 2001; 7(1):67-71. PubMed ID: 11349224
[TBL] [Abstract][Full Text] [Related]
24. [Survival and prognostic factors analysis of primitive neuroectodermal tumor].
Shen J; Yuan Y; Hu K; Lian X; Hou XR; Sun S; Yan JF; Liu ZK; Zhang FQ
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):614-618. PubMed ID: 30139033
[No Abstract] [Full Text] [Related]
25. Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis.
Picard D; Miller S; Hawkins CE; Bouffet E; Rogers HA; Chan TS; Kim SK; Ra YS; Fangusaro J; Korshunov A; Toledano H; Nakamura H; Hayden JT; Chan J; Lafay-Cousin L; Hu P; Fan X; Muraszko KM; Pomeroy SL; Lau CC; Ng HK; Jones C; Van Meter T; Clifford SC; Eberhart C; Gajjar A; Pfister SM; Grundy RG; Huang A
Lancet Oncol; 2012 Aug; 13(8):838-48. PubMed ID: 22691720
[TBL] [Abstract][Full Text] [Related]
26. [Expression of the neurotrophin-receptor TrkB predicts outcome in nephroblastomas: results of a pilot-study].
Eggert A; Grotzer MA; Zhao H; Brodeur GM; Evans AE
Klin Padiatr; 2001; 213(4):191-6. PubMed ID: 11528553
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.
Phi JH; Kim JH; Eun KM; Wang KC; Park KH; Choi SA; Kim YY; Park SH; Cho BK; Kim SK
J Neurosurg Pediatr; 2010 Jun; 5(6):608-14. PubMed ID: 20515335
[TBL] [Abstract][Full Text] [Related]
28. A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors.
Bruch LA; Hill DA; Cai DX; Levy BK; Dehner LP; Perry A
Hum Pathol; 2001 Feb; 32(2):156-62. PubMed ID: 11230702
[TBL] [Abstract][Full Text] [Related]
29. Amplification and overexpression of KIT, PDGFRA, and VEGFR2 in medulloblastomas and primitive neuroectodermal tumors.
Blom T; Roselli A; Häyry V; Tynninen O; Wartiovaara K; Korja M; Nordfors K; Haapasalo H; Nupponen NN
J Neurooncol; 2010 Apr; 97(2):217-24. PubMed ID: 19779861
[TBL] [Abstract][Full Text] [Related]
30. Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system.
Biegel JA; Fogelgren B; Zhou JY; James CD; Janss AJ; Allen JC; Zagzag D; Raffel C; Rorke LB
Clin Cancer Res; 2000 Jul; 6(7):2759-63. PubMed ID: 10914721
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
[TBL] [Abstract][Full Text] [Related]
32. [Hypermethylation as a potential prognostic factor and a clue to a better understanding of the molecular pathogenesis of medulloblastoma--results of a genomewide methylation scan].
Frühwald MC; O'Dorisio MS; Smith L; Dai Z; Wright FA; Paulus W; Jürgens H; Plass C
Klin Padiatr; 2001; 213(4):197-203. PubMed ID: 11528554
[TBL] [Abstract][Full Text] [Related]
33. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors.
Bobola MS; Finn LS; Ellenbogen RG; Geyer JR; Berger MS; Braga JM; Meade EH; Gross ME; Silber JR
Clin Cancer Res; 2005 Oct; 11(20):7405-14. PubMed ID: 16243814
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors and treatment results for supratentorial primitive neuroectodermal tumors in children using radiation and chemotherapy: a Childrens Cancer Group randomized trial.
Cohen BH; Zeltzer PM; Boyett JM; Geyer JR; Allen JC; Finlay JL; McGuire-Cullen P; Milstein JM; Rorke LB; Stanley P
J Clin Oncol; 1995 Jul; 13(7):1687-96. PubMed ID: 7602359
[TBL] [Abstract][Full Text] [Related]
35. Abundance of apoptotic neoplastic cells in diagnostic biopsy samples is not a prognostic factor in childhood primitive neuroectodermal tumors of the central nervous system.
Grotzer MA; Janss AJ; Fung KM; Sutton LN; Zhao H; Trojanowski JQ; Rorke LB; Phillips PC
J Pediatr Hematol Oncol; 2001 Jan; 23(1):25-9. PubMed ID: 11196266
[TBL] [Abstract][Full Text] [Related]
36. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
[TBL] [Abstract][Full Text] [Related]
37. Are clinical parameters valuable prognostic factors in childhood primitive neuroectodermal tumors? A multivariate analysis of 105 cases.
Michiels EM; Heikens J; Jansen MJ; Oldenburger F; Voûte T
Radiother Oncol; 2000 Mar; 54(3):229-38. PubMed ID: 10738081
[TBL] [Abstract][Full Text] [Related]
38. Supratentorial primitive neuroectodermal tumours of the brain: multidirectional differentiation does not influence prognosis. A clinicopathological report of 18 patients.
Visée S; Soltner C; Rialland X; Machet MC; Loussouarn D; Milinkevitch S; Pasco-Papon A; Mercier P; Rousselet MC
Histopathology; 2005 Apr; 46(4):403-12. PubMed ID: 15810952
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of MYCN, DDX1, TrkA, and TrkC gene transcripts expression in neuroblastoma.
de Souza DR; Sanabani SS; de Souza AC; Filho Odone V; Epelman S; Bendit I
Pediatr Blood Cancer; 2011 May; 56(5):749-56. PubMed ID: 21154590
[TBL] [Abstract][Full Text] [Related]
40. Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms' tumor.
Eggert A; Grotzer MA; Ikegaki N; Zhao H; Cnaan A; Brodeur GM; Evans AE
J Clin Oncol; 2001 Feb; 19(3):689-96. PubMed ID: 11157019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
